|
LAMB1 |
laminin, beta 1; Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components (1786 aa) |
|
SLC35D1 |
solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1; Transports both UDP-glucuronic acid (UDP-GlcA) and UDP-N-acetylgalactosamine (UDP-GalNAc) from the cytoplasm to into the endoplasmic reticulum lumen. Participates in glucuronidation and/or chondroitin sulfate biosynthesis (355 aa) |
|
COL10A1 |
collagen, type X, alpha 1; Type X collagen is a product of hypertrophic chondrocytes and has been localized to presumptive mineralization zones of hyaline cartilage (680 aa) |
|
LGALS3 |
lectin, galactoside-binding, soluble, 3; Mediates with the alpha-3, beta-1 integrin the stimulation by CSPG4 of endothelial cells migration. Together with DMBT1, required for terminal differentiation of columnar epithelial cells during early embryogenesis (250 aa) |
|
ACAN |
aggrecan; This proteoglycan is a major component of extracellular matrix of cartilaginous tissues. A major function of this protein is to resist compression in cartilage. It binds avidly to hyaluronic acid via an N-terminal globular region (2416 aa) |
|
PTH2R |
parathyroid hormone 2 receptor; This is a specific receptor for parathyroid hormone. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. PTH2R may be responsible for PTH effects in a number of physiological systems. (550 aa) |
|
FRZB |
frizzled-related protein; Soluble frizzled-related proteins (sFRPS) function as modulators of Wnt signaling through direct interaction with Wnts. They have a role in regulating cell growth and differentiation in specific cell types. SFRP3/FRZB is involved in limb skeletogenesis. Antagonist of Wnt8 signaling. Regulates chondrocyte maturation and long bone development (325 aa) |
|
MMP3 |
matrix metallopeptidase 3 (stromelysin 1, progelatinase); Can degrade fibronectin, laminin, gelatins of type I, III, IV, and V; collagens III, IV, X, and IX, and cartilage proteoglycans. Activates procollagenase (477 aa) |
|
COL3A1 |
collagen, type III, alpha 1; Collagen type III occurs in most soft connective tissues along with type I collagen (1466 aa) |
|
UGDH |
UDP-glucose dehydrogenase; Biosynthesis of glycosaminoglycans; hyaluronan, chondroitin sulfate, and heparan sulfate (494 aa) |
|
PTH1R |
parathyroid hormone 1 receptor; This is a receptor for parathyroid hormone and for parathyroid hormone-related peptide. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase and also a phosphatidylinositol-calcium second messenger system (593 aa) |
|
COL27A1 |
collagen, type XXVII, alpha 1; Plays a role during the calcification of cartilage and the transition of cartilage to bone (1860 aa) |
|
HYAL2 |
hyaluronoglucosaminidase 2; Hydrolyzes high molecular weight hyaluronic acid to produce an intermediate-sized product which is further hydrolyzed by sperm hyaluronidase to give small oligosaccharides. Associates with and negatively regulates MST1R (473 aa) |
|
COL24A1 |
collagen, type XXIV, alpha 1; Participates in regulating type I collagen fibrillogenesis during fetal development (1714 aa) |
|
COL5A1 |
collagen, type V, alpha 1; Type V collagen is a member of group I collagen (fibrillar forming collagen). It is a minor connective tissue component of nearly ubiquitous distribution. Type V collagen binds to heparan sulfate, thrombospondin, heparin, and insulin (1838 aa) |
|
MATN1 |
matrillin 1, cartilage matrix protein; A major component of the extracellular matrix of cartilage. It binds to collagen (496 aa) |
|
COL5A2 |
collagen, type V, alpha 2; Type V collagen is a member of group I collagen (fibrillar forming collagen). It is a minor connective tissue component of nearly ubiquitous distribution. Type V collagen binds to heparan sulfate, thrombospondin, heparin, and insulin. Type V collagen is a key determinant in the assembly of tissue-specific matrices (1499 aa) |